Gesamtpreis (1 Artikel Artikel):
Versandziel:
mita alain (28 Ergebnisse)
Direkt zu den wichtigsten Suchergebnissen
Suchfilter
Produktart
- Alle Product Types
- Bücher (28)
- Magazine & Zeitschriften (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Comics (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Noten (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Kunst, Grafik & Poster (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Fotografien (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Karten (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Manuskripte & Papierantiquitäten (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
Zustand Mehr dazu
- Neu (24)
- Wie Neu, Sehr Gut oder Gut Bis Sehr Gut (4)
- Gut oder Befriedigend (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Ausreichend oder Schlecht (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Wie beschrieben (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
Einband
Weitere Eigenschaften
- Erstausgabe (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Signiert (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Schutzumschlag (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Angebotsfoto (10)
- Keine Print-on-Demand Angebote (16)
Sprache (1)
Preis
- Beliebiger Preis
- Weniger als EUR 20 (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- EUR 20 bis EUR 45 (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Mehr als EUR 45
Gratisversand
- Kostenloser Versand nach USA (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
Land des Verkäufers
Verkäuferbewertung
-
Mtor Inhibition for Cancer Therapy : Past, Present and Future
Anbieter: GreatBookPrices, Columbia, MD, USA
Verkäuferbewertung 5 von 5 Sternen
EUR 111,58
EUR 2,26 Versand
Versand innerhalb von USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
-
mTOR Inhibition for Cancer Therapy: Past, Present and Future
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
EUR 103,00
EUR 13,83 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
-
mTOR Inhibition for Cancer Therapy: Past, Present and Future
Anbieter: Chiron Media, Wallingford, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
EUR 100,29
EUR 17,88 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: 10 verfügbar
In den WarenkorbPF. Zustand: New.
-
Mtor Inhibition for Cancer Therapy : Past, Present and Future
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
EUR 102,99
EUR 17,31 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
-
Mtor Inhibition For Cancer Therapy: Past
Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irland
Verkäuferbewertung 5 von 5 Sternen
Zustand: New.
-
Zustand: New. pp. 308 Reprint edition NO-PA16APR2015-KAP.
-
Mtor Inhibition For Cancer Therapy: Past
Anbieter: Kennys Bookstore, Olney, MD, USA
Verkäuferbewertung 5 von 5 Sternen
Zustand: New.
-
Taschenbuch. Zustand: Neu. mTOR Inhibition for Cancer Therapy: Past, Present and Future | Monica Mita (u. a.) | Taschenbuch | vi | Englisch | 2016 | Springer | EAN 9782817805573 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
-
Zustand: New. pp. 400.
-
mTOR Inhibition for Cancer Therapy: Past, Present and Future
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book describes the challenges involved in developing mTOR inhibitors for cancer treatment, starting with an in-depth examination of their molecular mechanism of action, with emphasis on the class side-effects, efficacy and mechanisms of resistance, as well as on promising novel directions for their development, including novel compounds and rational combinations with other anti-neoplastic drugs. Over the last 10 years, inhibitors of mTOR have emerged as a major class of anticancer drugs. Two rapamycin analogs are currently approved for the treatment of renal cell carcinoma, and it is estimated that a variety of other tumor types could benefit from mTOR inhibition, with numerous clinical trials (including pivotal registration trials) already underway. Second-generation small-molecule inhibitors of the pathway have also shown promise in terms of their superior tolerability and efficacy and are undergoing extensive clinical evaluation, with an estimated 30+ compoundscurrently under evaluation.
-
mTOR Inhibition for Cancer Therapy: Past, Present and Future
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
EUR 138,86
EUR 34,63 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. reprint edition. 300 pages. French language. 9.25x6.10x0.70 inches. In Stock.
-
mTOR Inhibition for Cancer Therapy: Past, Present and Future
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book describes the challenges involved in developing mTOR inhibitors for cancer treatment, starting with an in-depth examination of their molecular mechanism of action, with emphasis on the class side-effects, efficacy and mechanisms of resistance, as well as on promising novel directions for their development, including novel compounds and rational combinations with other anti-neoplastic drugs. Over the last 10 years, inhibitors of mTOR have emerged as a major class of anticancer drugs. Two rapamycin analogs are currently approved for the treatment of renal cell carcinoma, and it is estimated that a variety of other tumor types could benefit from mTOR inhibition, with numerous clinical trials (including pivotal registration trials) already underway. Second-generation small-molecule inhibitors of the pathway have also shown promise in terms of their superior tolerability and efficacy and are undergoing extensive clinical evaluation, with an estimated 30+ compoundscurrently under evaluation.
-
Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 308 | Sprache: Englisch | Produktart: Bücher | This book describes the challenges involved in developing mTOR inhibitors for cancer treatment, starting with an in-depth examination of their molecular mechanism of action, with emphasis on the class side-effects, efficacy and mechanisms of resistance, as well as on promising novel directions for their development, including novel compounds and rational combinations with other anti-neoplastic drugs. Over the last 10 years, inhibitors of mTOR have emerged as a major class of anticancer drugs. Two rapamycin analogs are currently approved for the treatment of renal cell carcinoma, and it is estimated that a variety of other tumor types could benefit from mTOR inhibition, with numerous clinical trials (including pivotal registration trials) already underway. Second-generation small-molecule inhibitors of the pathway have also shown promise in terms of their superior tolerability and efficacy and are undergoing extensive clinical evaluation, with an estimated 30+ compoundscurrently under evaluation.
-
Mtor Inhibition for Cancer Therapy : Past, Present and Future
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
EUR 187,82
EUR 17,31 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
-
mTOR Inhibition for Cancer Therapy: Past, Present and Future
Anbieter: Mispah books, Redhill, SURRE, Vereinigtes Königreich
Verkäuferbewertung 4 von 5 Sternen
EUR 178,32
EUR 28,85 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Like New. Like New. book.
-
Mtor Inhibition for Cancer Therapy : Past, Present and Future
Anbieter: GreatBookPrices, Columbia, MD, USA
Verkäuferbewertung 5 von 5 Sternen
EUR 211,05
EUR 2,26 Versand
Versand innerhalb von USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
-
mTOR Inhibition for Cancer Therapy: Past, Present and Future (eng)
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
Verkäuferbewertung 3 von 5 Sternen
EUR 86,24
EUR 6,80 Versand
Versand von Italien nach USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: new. Questo è un articolo print on demand.
-
mTOR Inhibition for Cancer Therapy: Pas (eng)
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
Verkäuferbewertung 3 von 5 Sternen
EUR 78,24
EUR 30,00 Versand
Versand von Italien nach USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: new. Questo è un articolo print on demand.
-
mTOR Inhibition for Cancer Therapy: Past, Present and Future
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book describes the challenges involved in developing mTOR inhibitors for cancer treatment, starting with an in-depth examination of their molecular mechanism of action, with emphasis on the class side-effects, efficacy and mechanisms of resistance, as well as on promising novel directions for their development, including novel compounds and rational combinations with other anti-neoplastic drugs. Over the last 10 years, inhibitors of mTOR have emerged as a major class of anticancer drugs. Two rapamycin analogs are currently approved for the treatment of renal cell carcinoma, and it is estimated that a variety of other tumor types could benefit from mTOR inhibition, with numerous clinical trials (including pivotal registration trials) already underway. Second-generation small-molecule inhibitors of the pathway have also shown promise in terms of their superior tolerability and efficacy and are undergoing extensive clinical evaluation, with an estimated 30+ compounds currently under evaluation. 308 pp. Englisch.
-
mTOR Inhibition for Cancer Therapy: Past, Present and Future
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book describes the challenges involved in developing mTOR inhibitors for cancer treatment, starting with an in-depth examination of their molecular mechanism of action, with emphasis on the class side-effects, efficacy and mechanisms of resistance, as well as on promising novel directions for their development, including novel compounds and rational combinations with other anti-neoplastic drugs. Over the last 10 years, inhibitors of mTOR have emerged as a major class of anticancer drugs. Two rapamycin analogs are currently approved for the treatment of renal cell carcinoma, and it is estimated that a variety of other tumor types could benefit from mTOR inhibition, with numerous clinical trials (including pivotal registration trials) already underway. Second-generation small-molecule inhibitors of the pathway have also shown promise in terms of their superior tolerability and efficacy and are undergoing extensive clinical evaluation, with an estimated 30+ compounds currently under evaluation. 308 pp. Englisch.
-
EUR 81,44
EUR 48,99 Versand
Versand von Deutschland nach USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. First book on that topicInput and perspectives by international leadersPreclinical and clinical data available on the subject have been integratedA dedicated chapter on toxicity profile of mTOR inhibitorsFuture directions for .
-
EUR 89,99
EUR 48,99 Versand
Versand von Deutschland nach USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbGebunden. Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. First book on that topicInput and perspectives by international leadersPreclinical and clinical data available on the subject have been integratedA dedicated chapter on toxicity profile of mTOR inhibitorsFuture directions for .
-
Mtor Inhibition for Cancer Therapy: Past, Present and Future
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Verkäuferbewertung 4 von 5 Sternen
EUR 146,31
EUR 7,50 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: 4 verfügbar
In den WarenkorbZustand: New. Print on Demand pp. 308.
-
mTOR Inhibition for Cancer Therapy: Past, Present and Future
Sprache: Englisch
Verlag: Springer, Springer Aug 2016, 2016
ISBN 10: 2817805577 ISBN 13: 9782817805573
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book describes the challenges involved in developing mTOR inhibitors for cancer treatment, starting with an in-depth examination of their molecular mechanism of action, with emphasis on the class side-effects, efficacy and mechanisms of resistance, as well as on promising novel directions for their development, including novel compounds and rational combinations with other anti-neoplastic drugs.Over the last 10 years, inhibitors of mTOR have emerged as a major class of anticancer drugs. Two rapamycin analogs are currently approved for the treatment of renal cell carcinoma, and it is estimated that a variety of other tumor types could benefit from mTOR inhibition, with numerous clinical trials (including pivotal registration trials) already underway. Second-generation small-molecule inhibitors of the pathway have also shown promise in terms of their superior tolerability and efficacy and are undergoing extensive clinical evaluation, with an estimated 30+ compoundscurrently under evaluation.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 308 pp. Englisch.
-
Mtor Inhibition for Cancer Therapy: Past, Present and Future
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Verkäuferbewertung 4 von 5 Sternen
Zustand: New. PRINT ON DEMAND pp. 308.
-
mTOR Inhibition for Cancer Therapy: Past, Present and Future
Sprache: Englisch
Verlag: Springer, Springer Dez 2015, 2015
ISBN 10: 2817804910 ISBN 13: 9782817804910
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Buch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book describes the challenges involved in developing mTOR inhibitors for cancer treatment, starting with an in-depth examination of their molecular mechanism of action, with emphasis on the class side-effects, efficacy and mechanisms of resistance, as well as on promising novel directions for their development, including novel compounds and rational combinations with other anti-neoplastic drugs.Over the last 10 years, inhibitors of mTOR have emerged as a major class of anticancer drugs. Two rapamycin analogs are currently approved for the treatment of renal cell carcinoma, and it is estimated that a variety of other tumor types could benefit from mTOR inhibition, with numerous clinical trials (including pivotal registration trials) already underway. Second-generation small-molecule inhibitors of the pathway have also shown promise in terms of their superior tolerability and efficacy and are undergoing extensive clinical evaluation, with an estimated 30+ compoundscurrently under evaluation.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 308 pp. Englisch.
-
MTOR Inhibition for Cancer Therapy
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Verkäuferbewertung 4 von 5 Sternen
EUR 166,17
EUR 7,50 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: 4 verfügbar
In den WarenkorbZustand: New. Print on Demand pp. 400 15 Illus. (Col.) This item is printed on demand.
-
MTOR Inhibition for Cancer Therapy
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Verkäuferbewertung 4 von 5 Sternen
Zustand: New. PRINT ON DEMAND pp. 400.
